HIV Complications and Co-Morbidities

HIV complications

The IMPAACT HIV Complications & Co-morbidities Scientific Committee aims to determine optimal and feasible methods for the prevention and management of co-infections and co-morbidities of HIV infection and its treatment.

 

 

 

Priorities include evaluation of:

  • Investigating potential neuroprotective and neurotoxic effects of ART to preserve neurocognitive development and mental health in infants, children, and adolescents
  • Refining and optimizing the evaluation and treatment of neurocognitive and mental health disorders, particularly executive dysfunction, depression and PTSD
  • Evaluating novel preventive and/or therapeutic approaches to high-priority diseases among pediatric populations with or affected by HIV, including respiratory syncytial virus (RSV), working with NIAID and other partners
  • Evaluating other co-morbidities and complications of importance for pediatric, adolescent and pregnant populations with HIV, with other partners and NIH institutes

Committee Contacts

Chair: Allison Agwu
Vice-Chair: Jackie Hoare
Operations Center: Jen LibousSarah Buisson, and Rachael Jeffrey

Presentations

 

Studies Within This Research Area